Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Combination Therapy of Anti-PD-1 Antibody and CSF-1R Inhibitor Reverses Induction of Suppressive Myeloid Cells and Controls Spontaneous Neuroblastoma Progression
KTH, School of Biotechnology (BIO), Proteomics and Nanobiotechnology.ORCID iD: 0000-0003-0344-8049
Show others and affiliations
2016 (English)In: Pediatric Blood & Cancer, ISSN 1545-5009, E-ISSN 1545-5017, Vol. 63, p. S28-S28Article in journal, Meeting abstract (Refereed) Published
Place, publisher, year, edition, pages
Wiley-Blackwell, 2016. Vol. 63, p. S28-S28
National Category
Cancer and Oncology Hematology
Identifiers
URN: urn:nbn:se:kth:diva-199552ISI: 000384818800426OAI: oai:DiVA.org:kth-199552DiVA, id: diva2:1065565
Note

QC 20170116

Available from: 2017-01-16 Created: 2017-01-09 Last updated: 2017-11-29Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records BETA

Reuterswärd, PhilippaSvahn Andersson, Helene

Search in DiVA

By author/editor
Reuterswärd, PhilippaSvahn Andersson, Helene
By organisation
Proteomics and Nanobiotechnology
In the same journal
Pediatric Blood & Cancer
Cancer and OncologyHematology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 117 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf